Net Assets for Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported net assets is $18.67B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$18.67B
YoY change
+13.7%
5Y CAGR
+16.5%
Peak year (2025)
$18.67B
Latest annual
$18.67B
Net Assets history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
Net Assets history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $18.67B | +13.7% | ||
| 2024 | $16.41B | -6.7% | ||
| 2023 | $17.58B | +26.4% | ||
| 2022 | $13.91B | +37.7% | ||
| 2021 | $10.10B | +16.3% | ||
| 2020 | $8.69B | +42.8% | ||
| 2019 | $6.09B | +37.2% | ||
| 2018 | $4.44B | +118.6% | ||
| 2017 | $2.03B | +75.4% | ||
| 2016 | $1.16B | +23.0% | ||
| 2015 | $939.97M | -12.6% | ||
| 2014 | $1.08B | -20.7% | ||
| 2013 | $1.36B | +35.8% | ||
| 2012 | $999.18M | +27.0% | ||
| 2011 | $786.84M | +56.1% | ||
| 2010 | $503.97M | -54.0% | ||
| 2009 | $1.10B | +359.0% | ||
| 2008 | $238.87M | -12.0% | ||
| 2007 | $271.30M | -46.4% | ||
| 2006 | $505.94M | +111.5% | ||
| 2005 | $239.18M | +574.9% | ||
| 2004 | $35.44M | -81.6% | ||
| 2003 | $192.84M | -49.1% | ||
| 2002 | $378.58M | -20.4% | ||
| 2001 | $475.35M | -7.5% | ||
| 2000 | $514.01M | +145.7% | ||
| 1999 | $209.23M | -15.0% | ||
| 1998 | $246.20M | -10.8% | ||
| 1997 | $276.00M | +111.0% | ||
| 1996 | $130.80M | +53.3% | ||
| 1995 | $85.30M | -19.1% | ||
| 1994 | $105.50M | +113.1% | ||
| 1993 | $49.50M | +12.8% | ||
| 1992 | $43.90M | -15.9% | ||
| 1991 | $52.20M | +903.8% | ||
| 1990 | $5.20M | — |
Net Assets values are taken from Vertex Pharmaceuticals's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Vertex Pharmaceuticals (VRTX) net assets totalled $18.67B – grew 13.7% year-over-year.
Vertex Pharmaceuticals net assets compound annual growth for the 2020–2025 (5 years) window is +16.5%, with the latest reading among the more recent periods of the dataset.
$18.67B stands as the all-time-high annual net assets, posted in 2025, against a low of $5.20M during 1990.
Among 8 Healthcare peers, Vertex Pharmaceuticals (VRTX) ranks 7th; the peer median for net assets is $50.64B.
Vertex Pharmaceuticals Net Assets by Year
Vertex Pharmaceuticals Net Assets 2025: $18.67B
Vertex Pharmaceuticals net assets in 2025 was $18.67B, grew 13.7% from 2024. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals Net Assets 2024: $16.41B
Vertex Pharmaceuticals net assets in 2024 was $16.41B, declined 6.7% below 2023.
Vertex Pharmaceuticals Net Assets 2023: $17.58B
Vertex Pharmaceuticals net assets in 2023 was $17.58B, grew 26.4% from 2022.
Vertex Pharmaceuticals Net Assets 2022: $13.91B
Vertex Pharmaceuticals net assets in 2022 was $13.91B, surged 37.7% from 2021.
Vertex Pharmaceuticals Net Assets 2021: $10.10B
Vertex Pharmaceuticals net assets in 2021 was $10.10B.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers — Net Assets
Companies in the same sector as Vertex Pharmaceuticals, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Vertex Pharmaceuticals's net assets?
- Latest reported net assets for Vertex Pharmaceuticals (VRTX) is $18.67B (period ending December 31, 2025).
How has Vertex Pharmaceuticals net assets changed year-over-year?
- Vertex Pharmaceuticals (VRTX) net assets changed +13.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Vertex Pharmaceuticals net assets?
- Vertex Pharmaceuticals (VRTX) net assets compound annual growth rate is +16.5% over the most recent 5 years available.
When did Vertex Pharmaceuticals net assets hit its highest annual value?
- Vertex Pharmaceuticals net assets reached its highest annual value of $18.67B in 2025.
What was Vertex Pharmaceuticals net assets in 2024?
- Vertex Pharmaceuticals (VRTX) net assets in 2024 was $16.41B.
What was Vertex Pharmaceuticals net assets in 2025?
- Vertex Pharmaceuticals (VRTX) net assets in 2025 was $18.67B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
VRTX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.